
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects
Keith P. Klugman, Steven Black
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 12896-12901
Open Access | Times Cited: 170
Keith P. Klugman, Steven Black
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 12896-12901
Open Access | Times Cited: 170
Showing 1-25 of 170 citing articles:
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J L Murray, Kevin S Ikuta, Fablina Sharara, et al.
The Lancet (2022) Vol. 399, Iss. 10325, pp. 629-655
Open Access | Times Cited: 9793
Christopher J L Murray, Kevin S Ikuta, Fablina Sharara, et al.
The Lancet (2022) Vol. 399, Iss. 10325, pp. 629-655
Open Access | Times Cited: 9793
The role of vaccines in combatting antimicrobial resistance
Francesca Micoli, Fábio Bagnoli, Rino Rappuoli, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 5, pp. 287-302
Open Access | Times Cited: 353
Francesca Micoli, Fábio Bagnoli, Rino Rappuoli, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 5, pp. 287-302
Open Access | Times Cited: 353
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Jayaseelan Murugaiyan, P. Anand Kumar, G. Srinivasa Rao, et al.
Antibiotics (2022) Vol. 11, Iss. 2, pp. 200-200
Open Access | Times Cited: 312
Jayaseelan Murugaiyan, P. Anand Kumar, G. Srinivasa Rao, et al.
Antibiotics (2022) Vol. 11, Iss. 2, pp. 200-200
Open Access | Times Cited: 312
Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 287
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 287
The disease burden of influenza beyond respiratory illness
Alejandro E. Macías, Janet E. McElhaney, Sandra S. Chaves, et al.
Vaccine (2020) Vol. 39, pp. A6-A14
Open Access | Times Cited: 242
Alejandro E. Macías, Janet E. McElhaney, Sandra S. Chaves, et al.
Vaccine (2020) Vol. 39, pp. A6-A14
Open Access | Times Cited: 242
Immunization: vital progress, unfinished agenda
Peter Piot, Heidi J. Larson, Katherine L. O’Brien, et al.
Nature (2019) Vol. 575, Iss. 7781, pp. 119-129
Open Access | Times Cited: 169
Peter Piot, Heidi J. Larson, Katherine L. O’Brien, et al.
Nature (2019) Vol. 575, Iss. 7781, pp. 119-129
Open Access | Times Cited: 169
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline
Isabel Frost, Hatim Sati, Pilar García-Vello, et al.
The Lancet Microbe (2022) Vol. 4, Iss. 2, pp. e113-e125
Open Access | Times Cited: 103
Isabel Frost, Hatim Sati, Pilar García-Vello, et al.
The Lancet Microbe (2022) Vol. 4, Iss. 2, pp. e113-e125
Open Access | Times Cited: 103
Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens
Yosra A. Helmy, Khaled Taha-Abdelaziz, Hanan Abd El-Halim Hawwas, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 274-274
Open Access | Times Cited: 97
Yosra A. Helmy, Khaled Taha-Abdelaziz, Hanan Abd El-Halim Hawwas, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 274-274
Open Access | Times Cited: 97
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 47
Ramanan Laxminarayan, Isabella Impalli, Radha Rangarajan, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2534-2550
Closed Access | Times Cited: 47
Antimicrobial resistance: a concise update
Charlotte Shan Ho, Carlos T H Wong, Thet Tun Aung, et al.
The Lancet Microbe (2024), pp. 100947-100947
Open Access | Times Cited: 37
Charlotte Shan Ho, Carlos T H Wong, Thet Tun Aung, et al.
The Lancet Microbe (2024), pp. 100947-100947
Open Access | Times Cited: 37
Programmed Nanocloak of Commensal Bacteria-Derived Nanovesicles Amplify Strong Immunoreactivity against Tumor Growth and Metastatic Progression
Jingjing Zhang, Shuangshuang Wan, Hao Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9613-9626
Closed Access | Times Cited: 20
Jingjing Zhang, Shuangshuang Wan, Hao Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9613-9626
Closed Access | Times Cited: 20
Antimicrobial resistance and the role of vaccines
David E. Bloom, Steven Black, David Salisbury, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 12868-12871
Open Access | Times Cited: 147
David E. Bloom, Steven Black, David Salisbury, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51, pp. 12868-12871
Open Access | Times Cited: 147
Synthetic carbohydrate-based vaccines: challenges and opportunities
M. Ravinder, Chiang-Yun Chen, Chung‐Yi Wu
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 129
M. Ravinder, Chiang-Yun Chen, Chung‐Yi Wu
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 129
Vaccine confidence: the keys to restoring trust
Selim Badur, Martin O. C. Ota, Serdar Öztürk, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 5, pp. 1007-1017
Open Access | Times Cited: 125
Selim Badur, Martin O. C. Ota, Serdar Öztürk, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 5, pp. 1007-1017
Open Access | Times Cited: 125
Childhood vaccines and antibiotic use in low- and middle-income countries
Joseph A. Lewnard, Nathan C. Lo, Nimalan Arinaminpathy, et al.
Nature (2020) Vol. 581, Iss. 7806, pp. 94-99
Open Access | Times Cited: 109
Joseph A. Lewnard, Nathan C. Lo, Nimalan Arinaminpathy, et al.
Nature (2020) Vol. 581, Iss. 7806, pp. 94-99
Open Access | Times Cited: 109
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection
Myeongjin Choi, Nicolas Hégerlé, Joseph Nkeze, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 101
Myeongjin Choi, Nicolas Hégerlé, Joseph Nkeze, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 101
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework
Johan Vekemans, Mateusz Hasso-Agopsowicz, Gagandeep Kang, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 4, pp. e1011-e1017
Open Access | Times Cited: 99
Johan Vekemans, Mateusz Hasso-Agopsowicz, Gagandeep Kang, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 4, pp. e1011-e1017
Open Access | Times Cited: 99
Alternatives to Antibiotics: A Symposium on the Challenges and Solutions for Animal Health and Production
Todd R. Callaway, Hyun S. Lillehoj, Rungtip Chuanchuen, et al.
Antibiotics (2021) Vol. 10, Iss. 5, pp. 471-471
Open Access | Times Cited: 70
Todd R. Callaway, Hyun S. Lillehoj, Rungtip Chuanchuen, et al.
Antibiotics (2021) Vol. 10, Iss. 5, pp. 471-471
Open Access | Times Cited: 70
Strengths and weaknesses of pneumococcal conjugate vaccines
Francesca Micoli, Maria Rosaria Romano, Filippo Carboni, et al.
Glycoconjugate Journal (2023) Vol. 40, Iss. 2, pp. 135-148
Open Access | Times Cited: 40
Francesca Micoli, Maria Rosaria Romano, Filippo Carboni, et al.
Glycoconjugate Journal (2023) Vol. 40, Iss. 2, pp. 135-148
Open Access | Times Cited: 40
Antibiotics in Dentistry: A Narrative Review of the Evidence beyond the Myth
Maria Contaldo, Francesco D’Ambrosio, Giuseppe Andrea Ferraro, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 11, pp. 6025-6025
Open Access | Times Cited: 35
Maria Contaldo, Francesco D’Ambrosio, Giuseppe Andrea Ferraro, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 11, pp. 6025-6025
Open Access | Times Cited: 35
Genomics for public health and international surveillance of antimicrobial resistance
Kate S. Baker, Elita Jauneikaite, Katie L. Hopkins, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 12, pp. e1047-e1055
Open Access | Times Cited: 33
Kate S. Baker, Elita Jauneikaite, Katie L. Hopkins, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 12, pp. e1047-e1055
Open Access | Times Cited: 33
Trends inStreptococcus pneumoniaeAntimicrobial Resistance in US Children: A Multicenter Evaluation
Salini Mohanty, Kristen A. Feemster, Kalvin Yu, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 22
Salini Mohanty, Kristen A. Feemster, Kalvin Yu, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 3
Open Access | Times Cited: 22
Environmental health hazards of untreated livestock wastewater: potential risks and future perspectives
Xiaomei Wu, Shah Nawaz, Ying Li, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 17, pp. 24745-24767
Closed Access | Times Cited: 12
Xiaomei Wu, Shah Nawaz, Ying Li, et al.
Environmental Science and Pollution Research (2024) Vol. 31, Iss. 17, pp. 24745-24767
Closed Access | Times Cited: 12
Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction
Dodi Safari, Wa Ode Dwi Daningrat, Jennifer Milucky, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0297041-e0297041
Open Access | Times Cited: 9
Dodi Safari, Wa Ode Dwi Daningrat, Jennifer Milucky, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0297041-e0297041
Open Access | Times Cited: 9
Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
Chiara Scelfo, Francesco Menzella, Matteo Fontana, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 420-420
Open Access | Times Cited: 54
Chiara Scelfo, Francesco Menzella, Matteo Fontana, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 420-420
Open Access | Times Cited: 54